43742-0379 NDC - LYMPH SPLEEN COMBO (CASTANEA VESCA, JUNIPERUS COMMUNIS, PHYTOLACCA DECANDRA, QUERCUS GLANDIUM SPIRITUS, MYOSOTIS ARVENSIS, NATRUM SULPHURICUM, CEANOTHUS AMERICANUS, HELIANTHUS ANNUUS, NATRUM MURIATICUM, LYMPH (SUIS), SPLEEN (SUIS), THYMUS (SUIS), CHININUM ARSENICOSUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, COENZYME Q10, FERRUM METALLICUM, SUCCINUM, APIS MELLIFICA)

Drug Information

Product NDC: 43742-0379

Proprietary Name: Lymph Spleen Combo

Non Proprietary Name: Castanea Vesca, Juniperus Communis, Phytolacca Decandra, Quercus Glandium Spiritus, Myosotis Arvensis, Natrum Sulphuricum, Ceanothus Americanus, Helianthus Annuus, Natrum Muriaticum, Lymph (Suis), Spleen (Suis), Thymus (Suis), Chininum Arsenicosum, Adenosinum Triphosphoricum Dinatrum, Coenzyme Q10, Ferrum Metallicum, Succinum, Apis Mellifica

Active Ingredient(s):
  • 3 [hp_X]/mL CASTANEA SATIVA LEAF;
  • 3 [hp_X]/mL JUNIPERUS COMMUNIS WHOLE;
  • 3 [hp_X]/mL PHYTOLACCA AMERICANA ROOT;
  • 4 [hp_X]/mL QUERCUS ROBUR NUT;
  • 6 [hp_X]/mL MYOSOTIS ARVENSIS;
  • 6 [hp_X]/mL SODIUM SULFATE;
  • 6 [hp_X]/mL CEANOTHUS AMERICANUS LEAF;
  • 6 [hp_X]/mL HELIANTHUS ANNUUS FLOWERING TOP;
  • 6 [hp_X]/mL SODIUM CHLORIDE;
  • 8 [hp_X]/mL SUS SCROFA LYMPH;
  • 8 [hp_X]/mL SUS SCROFA SPLEEN;
  • 8 [hp_X]/mL SUS SCROFA THYMUS;
  • 8 [hp_X]/mL QUININE ARSENATE;
  • 12 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM;
  • 12 [hp_X]/mL UBIDECARENONE;
  • 30 [hp_X]/mL IRON;
  • 30 [hp_X]/mL AMBER;
  • 200 [hp_C]/mL APIS MELLIFERA


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Labeler Information

Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:2/18/2014
End Marketing Date:6/29/2022

Package Information

No. Package Code Package Description Billing Unit
143742-0379-130 mL in 1 BOTTLE, DROPPER (43742-0379-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-0379The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELymph Spleen ComboThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECastanea Vesca, Juniperus Communis, Phytolacca Decandra, Quercus Glandium Spiritus, Myosotis Arvensis, Natrum Sulphuricum, Ceanothus Americanus, Helianthus Annuus, Natrum Muriaticum, Lymph (Suis), Spleen (Suis), Thymus (Suis), Chininum Arsenicosum, Adenosinum Triphosphoricum Dinatrum, Coenzyme Q10, Ferrum Metallicum, Succinum, Apis MellificaThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE2/18/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE6/29/2022This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMECASTANEA SATIVA LEAF; JUNIPERUS COMMUNIS WHOLE; PHYTOLACCA AMERICANA ROOT; QUERCUS ROBUR NUT; MYOSOTIS ARVENSIS; SODIUM SULFATE; CEANOTHUS AMERICANUS LEAF; HELIANTHUS ANNUUS FLOWERING TOP; SODIUM CHLORIDE; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; QUININE ARSENATE; ADENOSINE TRIPHOSPHATE DISODIUM; UBIDECARENONE; IRON; AMBER; APIS MELLIFERAThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 3; 3; 4; 6; 6; 6; 6; 6; 8; 8; 8; 8; 12; 12; 30; 30; 200 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 9/13/2019